Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Cytoreductive nephrectomy in mRCC

Here, Bradley McGregor, MD, of the Dana-Farber Cancer Institute, Boston, MA, discusses the role of cytoreductive nephrectomy in metastatic renal cell carcinoma (mRCC). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.